StockData
Ingevity Corp logo

Ingevity Corp (NGVT) stock

NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30134% above fair value
$53.75−2.21 (-3.95%)

Close on Nov 20, 2026Market cap $1.85BP/E 36.6Yield –

Ingevity gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Ingevity's gross profit for the twelve months ending Jun 30, 2026 was $477.10M, up 1.3% year over year. For fiscal 2025 it was $461.50M, down 0.7% from the year before. Over ten years it grew 5.3% a year on average. The highest annual figure on record is $570.10M in fiscal 2022.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$461.50M-0.7%
FY2024Dec 31, 2024$464.80M+4.4%
FY2023Dec 31, 2023$445.00M-21.9%
FY2022Dec 31, 2022$570.10M+11.2%
FY2021Dec 31, 2021$512.80M+10.2%
FY2020Dec 31, 2020$465.50M-3.4%
FY2019Dec 31, 2019$482.00M+15.6%
FY2018Dec 31, 2018$416.80M+26.7%
FY2017Dec 31, 2017$329.00M+19.9%
FY2016Dec 31, 2016$274.40M-0.4%
FY2015Dec 31, 2015$275.40M-13.5%
FY2014Dec 31, 2014$318.50M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$139.00M+8.8%
Q1 FY2026Mar 31, 2026$116.40M+4.0%
Q4 FY2025Dec 31, 2025$87.80M-12.1%
Q3 FY2025Sep 30, 2025$133.90M+1.7%
Q2 FY2025Jun 30, 2025$127.80M+3.7%
Q1 FY2025Mar 31, 2025$111.90M+12.2%
Q4 FY2024Dec 31, 2024$99.90M+206.4%
Q3 FY2024Sep 30, 2024$131.60M+2.0%
Q2 FY2024Jun 30, 2024$123.20M-19.5%
Q1 FY2024Mar 31, 2024$99.70M-23.5%
Q4 FY2023Dec 31, 2023$32.60M-69.1%
Q3 FY2023Sep 30, 2023$129.00M-26.8%
Q2 FY2023Jun 30, 2023$153.00M+1.6%
Q1 FY2023Mar 31, 2023$130.40M-5.4%
Q4 FY2022Dec 31, 2022$105.40M+0.4%
Q3 FY2022Sep 30, 2022$176.30M+24.3%
Q2 FY2022Jun 30, 2022$150.60M+7.7%
Q1 FY2022Mar 31, 2022$137.80M+9.2%
Q4 FY2021Dec 31, 2021$105.00M-17.6%
Q3 FY2021Sep 30, 2021$141.80M+1.6%
Q2 FY2021Jun 30, 2021$139.80M+66.6%
Q1 FY2021Mar 31, 2021$126.20M+10.1%
Q4 FY2020Dec 31, 2020$127.40M+14.8%
Q3 FY2020Sep 30, 2020$139.60M+0.1%
Q2 FY2020Jun 30, 2020$83.90M-37.6%
Q1 FY2020Mar 31, 2020$114.60M+18.0%
Q4 FY2019Dec 31, 2019$111.00M+13.7%
Q3 FY2019Sep 30, 2019$139.50M+17.6%
Q2 FY2019Jun 30, 2019$134.40M+16.4%
Q1 FY2019Mar 31, 2019$97.10M+14.1%
Q4 FY2018Dec 31, 2018$97.60M+29.6%
Q3 FY2018Sep 30, 2018$118.60M+27.3%
Q2 FY2018Jun 30, 2018$115.50M+28.6%
Q1 FY2018Mar 31, 2018$85.10M+20.4%
Q4 FY2017Dec 31, 2017$75.30M+33.7%
Q3 FY2017Sep 30, 2017$93.20M+15.9%
Q2 FY2017Jun 30, 2017$89.80M–
Q1 FY2017Mar 31, 2017$70.70M–
Q4 FY2016Dec 31, 2016$56.30M–
Q3 FY2016Sep 30, 2016$80.40M–

More Ingevity figures

See a number that looks wrong?